Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries
Author(s) -
Lawrence A. Garcia,
Michael R. Jaff,
Christopher Metzger,
Gino Sedillo,
Ashish Pershad,
Frank Zidar,
Raghotham Patlola,
R. Wilkins,
Andrey Espinoza,
Ayman Iskander,
George S. Khammar,
Yazan Khatib,
Robert Beasley,
Satyaprakash Makam,
Richard Kovach,
Suraj Kamat,
Luis R. León,
William Britton Eaves,
Jeffrey J. Popma,
Laura Mauri,
Dennis Donohoe,
Carol C. Base,
Kenneth Rosenfield
Publication year - 2015
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.113.000937
Subject(s) - medicine , stent , popliteal artery , surgery , investigational device exemption , restenosis , revascularization , percutaneous , radiology , femoral artery , critical limb ischemia , amputation , clinical trial , vascular disease , cardiology , myocardial infarction , arterial disease
Stent-based therapy in the superficial femoral and popliteal arteries in patients with peripheral artery disease is compromised by restenosis and risk of stent fracture or distortion. A novel self-expanding nitinol stent was developed that incorporates an interwoven-wire design (Supera stent, IDEV Technologies, Inc, Webster, TX) to confer greater radial strength, flexibility, and fracture resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom